Merck EPS - Earnings per Share 2010-2024 | MRK

Merck earnings per share (EPS) for the twelve months ending December 31, 2024 was $6.74, a 4714.29% increase year-over-year.

  • Merck EPS for the quarter ending December 31, 2024 was $1.49, a 410.42% decline year-over-year.
  • Merck 2024 annual EPS was $6.74, a 4714.29% increase from 2023.
  • Merck 2023 annual EPS was $0.14, a 97.55% decline from 2022.
  • Merck 2022 annual EPS was $5.71, a 11.09% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Merck EPS - Earnings per Share 2010-2024 | MRK

  • Merck EPS for the quarter ending December 31, 2024 was $1.49, a 410.42% decline year-over-year.
  • Merck 2024 annual EPS was $6.74, a 4714.29% increase from 2023.
  • Merck 2023 annual EPS was $0.14, a 97.55% decline from 2022.
  • Merck 2022 annual EPS was $5.71, a 11.09% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B